Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI-1020 vs Budesonide in Smokers with Asthma
NCT00327808Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tpi-1020 in asthma (2 arms), sponsored by Syntara Limited. Primary endpoint: Safety and tolerability of multiple doses of TPI-1020 at 22 days. Started May 2006; status: completed.
02
Drugs
tpi-1020
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00327808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327808.